Showing results (71-80 of 122) with videos related to

Sort By:
Pageof 13
Pharmaceuticals (Basel, Switzerland)|September 28, 2021
Privileged Quinolylnitrones for the Combined Therapy of Ischemic Stroke and Alzheimer's DiseaseJosé M Alonso, Alejandro Escobar-Peso, Alejandra Palomino-Antolín, et al.
Scientific Reports|July 19, 2022
Un-biased housekeeping gene panel selection for high-validity gene expression analysisAna I Casas, Ahmed A Hassan, Quirin Manz, et al.
Diseases (Basel, Switzerland)|April 30, 2021
Toxicology of Blister Agents: Is Melatonin a Potential Therapeutic Option?Alejandro Romero, Eva Ramos, Francisco López-Muñoz, et al.
Archives of Toxicology|January 19, 2025
BMP6 participates in the molecular mechanisms involved in APAP hepatotoxicityPatricia Marañón, Stephania C Isaza, Esther Rey, et al.
ASN Neuro|November 27, 2014
Both creatine and its product phosphocreatine reduce oxidative stress and afford neuroprotection in an in vitro Parkinson's modelMauricio Peña Cunha, Maria D Martín-de-Saavedra, Alejandro Romero, et al.
The European Journal of Neuroscience|November 8, 2007
Neuroprotectant minocycline depresses glutamatergic neurotransmission and Ca(2+) signalling in hippocampal neuronsJosé Carlos González, Javier Egea, María Del Carmen Godino, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 11, 2009
Mitochondrial Na+/Ca2+-exchanger blocker CGP37157 protects against chromaffin cell death elicited by veratridineSantos M Nicolau, Antonio M G de Diego, Lorena Cortés, et al.
Molecules (Basel, Switzerland)|April 20, 2019
QuinoxalineTacrine QT78, a Cholinesterase Inhibitor as a Potential Ligand for Alzheimer's Disease TherapyEva Ramos, Alejandra Palomino-Antolín, Manuela Bartolini, et al.
Pageof 13